nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—CYP1A2—Carmustine—malignant glioma	0.245	1	CbGbCtD
Pentoxifylline—PDE5A—endothelium—malignant glioma	0.0142	0.0683	CbGeAlD
Pentoxifylline—PDE5A—blood vessel—malignant glioma	0.0131	0.063	CbGeAlD
Pentoxifylline—NT5E—embryo—malignant glioma	0.0121	0.0579	CbGeAlD
Pentoxifylline—NT5E—retina—malignant glioma	0.0107	0.0512	CbGeAlD
Pentoxifylline—NT5E—telencephalon—malignant glioma	0.0098	0.0471	CbGeAlD
Pentoxifylline—Caffeine—PIK3CD—malignant glioma	0.0092	0.361	CrCbGaD
Pentoxifylline—Caffeine—PIK3CB—malignant glioma	0.0092	0.361	CrCbGaD
Pentoxifylline—PDE4A—telencephalon—malignant glioma	0.00748	0.0359	CbGeAlD
Pentoxifylline—Caffeine—PIK3CA—malignant glioma	0.00712	0.279	CrCbGaD
Pentoxifylline—NT5E—midbrain—malignant glioma	0.00704	0.0338	CbGeAlD
Pentoxifylline—ADORA2A—telencephalon—malignant glioma	0.00698	0.0335	CbGeAlD
Pentoxifylline—PDE5A—retina—malignant glioma	0.00692	0.0332	CbGeAlD
Pentoxifylline—NT5E—spinal cord—malignant glioma	0.00687	0.033	CbGeAlD
Pentoxifylline—PDE5A—telencephalon—malignant glioma	0.00636	0.0305	CbGeAlD
Pentoxifylline—Influenza-like symptoms—Temozolomide—malignant glioma	0.00626	0.0285	CcSEcCtD
Pentoxifylline—Scotoma—Carmustine—malignant glioma	0.0061	0.0277	CcSEcCtD
Pentoxifylline—ADORA1—telencephalon—malignant glioma	0.00603	0.029	CbGeAlD
Pentoxifylline—Scotoma—Temozolomide—malignant glioma	0.00589	0.0268	CcSEcCtD
Pentoxifylline—Cholestasis—Temozolomide—malignant glioma	0.00589	0.0268	CcSEcCtD
Pentoxifylline—NT5E—central nervous system—malignant glioma	0.00557	0.0267	CbGeAlD
Pentoxifylline—ADORA2A—spinal cord—malignant glioma	0.00489	0.0235	CbGeAlD
Pentoxifylline—ADORA2B—central nervous system—malignant glioma	0.00477	0.0229	CbGeAlD
Pentoxifylline—ADORA1—medulla oblongata—malignant glioma	0.00474	0.0227	CbGeAlD
Pentoxifylline—ADORA2B—cerebellum—malignant glioma	0.00466	0.0224	CbGeAlD
Pentoxifylline—PDE4B—telencephalon—malignant glioma	0.00446	0.0214	CbGeAlD
Pentoxifylline—NT5E—brain—malignant glioma	0.00442	0.0212	CbGeAlD
Pentoxifylline—Influenza like illness—Temozolomide—malignant glioma	0.00434	0.0198	CcSEcCtD
Pentoxifylline—ADORA1—midbrain—malignant glioma	0.00433	0.0208	CbGeAlD
Pentoxifylline—ADORA1—spinal cord—malignant glioma	0.00423	0.0203	CbGeAlD
Pentoxifylline—Aplastic anaemia—Temozolomide—malignant glioma	0.0042	0.0191	CcSEcCtD
Pentoxifylline—PDE4A—cerebellum—malignant glioma	0.00416	0.02	CbGeAlD
Pentoxifylline—ADORA2A—central nervous system—malignant glioma	0.00397	0.0191	CbGeAlD
Pentoxifylline—ADORA2A—cerebellum—malignant glioma	0.00388	0.0186	CbGeAlD
Pentoxifylline—Swelling—Carmustine—malignant glioma	0.00381	0.0173	CcSEcCtD
Pentoxifylline—Ear pain—Temozolomide—malignant glioma	0.00381	0.0173	CcSEcCtD
Pentoxifylline—ADORA2B—brain—malignant glioma	0.00379	0.0182	CbGeAlD
Pentoxifylline—Vascular purpura—Temozolomide—malignant glioma	0.00363	0.0165	CcSEcCtD
Pentoxifylline—PDE5A—central nervous system—malignant glioma	0.00362	0.0174	CbGeAlD
Pentoxifylline—Nasal congestion—Temozolomide—malignant glioma	0.00357	0.0162	CcSEcCtD
Pentoxifylline—PDE5A—cerebellum—malignant glioma	0.00353	0.017	CbGeAlD
Pentoxifylline—PDE4B—medulla oblongata—malignant glioma	0.0035	0.0168	CbGeAlD
Pentoxifylline—ADORA1—central nervous system—malignant glioma	0.00343	0.0165	CbGeAlD
Pentoxifylline—Thirst—Temozolomide—malignant glioma	0.00341	0.0155	CcSEcCtD
Pentoxifylline—PDE4A—brain—malignant glioma	0.00338	0.0162	CbGeAlD
Pentoxifylline—Purpura—Temozolomide—malignant glioma	0.00337	0.0153	CcSEcCtD
Pentoxifylline—ADORA1—cerebellum—malignant glioma	0.00335	0.0161	CbGeAlD
Pentoxifylline—PDE4B—midbrain—malignant glioma	0.0032	0.0154	CbGeAlD
Pentoxifylline—ADORA2A—brain—malignant glioma	0.00315	0.0151	CbGeAlD
Pentoxifylline—PDE4B—spinal cord—malignant glioma	0.00313	0.015	CbGeAlD
Pentoxifylline—PDE5A—brain—malignant glioma	0.00287	0.0138	CbGeAlD
Pentoxifylline—Abdominal distension—Temozolomide—malignant glioma	0.00283	0.0129	CcSEcCtD
Pentoxifylline—Pancytopenia—Carmustine—malignant glioma	0.00276	0.0125	CcSEcCtD
Pentoxifylline—ADORA1—brain—malignant glioma	0.00272	0.0131	CbGeAlD
Pentoxifylline—Pancytopenia—Temozolomide—malignant glioma	0.00267	0.0121	CcSEcCtD
Pentoxifylline—PDE4B—central nervous system—malignant glioma	0.00254	0.0122	CbGeAlD
Pentoxifylline—Infestation—Temozolomide—malignant glioma	0.0025	0.0114	CcSEcCtD
Pentoxifylline—Infestation NOS—Temozolomide—malignant glioma	0.0025	0.0114	CcSEcCtD
Pentoxifylline—PDE4B—cerebellum—malignant glioma	0.00248	0.0119	CbGeAlD
Pentoxifylline—Hepatobiliary disease—Temozolomide—malignant glioma	0.00237	0.0108	CcSEcCtD
Pentoxifylline—Haemoglobin—Carmustine—malignant glioma	0.00234	0.0106	CcSEcCtD
Pentoxifylline—Haemorrhage—Carmustine—malignant glioma	0.00232	0.0106	CcSEcCtD
Pentoxifylline—Haemoglobin—Temozolomide—malignant glioma	0.00226	0.0103	CcSEcCtD
Pentoxifylline—Haemorrhage—Temozolomide—malignant glioma	0.00225	0.0102	CcSEcCtD
Pentoxifylline—Hepatitis—Temozolomide—malignant glioma	0.00225	0.0102	CcSEcCtD
Pentoxifylline—Flushing—Carmustine—malignant glioma	0.00216	0.00982	CcSEcCtD
Pentoxifylline—Flushing—Temozolomide—malignant glioma	0.00209	0.00949	CcSEcCtD
Pentoxifylline—Arrhythmia—Carmustine—malignant glioma	0.00208	0.00945	CcSEcCtD
Pentoxifylline—Immune system disorder—Temozolomide—malignant glioma	0.00203	0.00923	CcSEcCtD
Pentoxifylline—Erythema—Carmustine—malignant glioma	0.00202	0.00921	CcSEcCtD
Pentoxifylline—PDE4B—brain—malignant glioma	0.00201	0.00966	CbGeAlD
Pentoxifylline—Back pain—Carmustine—malignant glioma	0.00196	0.00891	CcSEcCtD
Pentoxifylline—Erythema—Temozolomide—malignant glioma	0.00196	0.0089	CcSEcCtD
Pentoxifylline—Dysgeusia—Temozolomide—malignant glioma	0.00192	0.00871	CcSEcCtD
Pentoxifylline—Vision blurred—Carmustine—malignant glioma	0.00191	0.00868	CcSEcCtD
Pentoxifylline—Tremor—Carmustine—malignant glioma	0.0019	0.00863	CcSEcCtD
Pentoxifylline—Back pain—Temozolomide—malignant glioma	0.00189	0.00861	CcSEcCtD
Pentoxifylline—Anaemia—Carmustine—malignant glioma	0.00187	0.00851	CcSEcCtD
Pentoxifylline—Agitation—Carmustine—malignant glioma	0.00186	0.00846	CcSEcCtD
Pentoxifylline—Vision blurred—Temozolomide—malignant glioma	0.00184	0.00838	CcSEcCtD
Pentoxifylline—Tremor—Temozolomide—malignant glioma	0.00183	0.00834	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Temozolomide—malignant glioma	0.00181	0.00825	CcSEcCtD
Pentoxifylline—Leukopenia—Carmustine—malignant glioma	0.00181	0.00824	CcSEcCtD
Pentoxifylline—Anaemia—Temozolomide—malignant glioma	0.00181	0.00822	CcSEcCtD
Pentoxifylline—Agitation—Temozolomide—malignant glioma	0.0018	0.00818	CcSEcCtD
Pentoxifylline—Angioedema—Temozolomide—malignant glioma	0.00179	0.00813	CcSEcCtD
Pentoxifylline—Malaise—Temozolomide—malignant glioma	0.00176	0.00802	CcSEcCtD
Pentoxifylline—Convulsion—Carmustine—malignant glioma	0.00175	0.00798	CcSEcCtD
Pentoxifylline—Leukopenia—Temozolomide—malignant glioma	0.00175	0.00796	CcSEcCtD
Pentoxifylline—Hypertension—Carmustine—malignant glioma	0.00175	0.00795	CcSEcCtD
Pentoxifylline—Palpitations—Temozolomide—malignant glioma	0.00173	0.00786	CcSEcCtD
Pentoxifylline—Myalgia—Carmustine—malignant glioma	0.00172	0.00784	CcSEcCtD
Pentoxifylline—Chest pain—Carmustine—malignant glioma	0.00172	0.00784	CcSEcCtD
Pentoxifylline—Anxiety—Carmustine—malignant glioma	0.00172	0.00781	CcSEcCtD
Pentoxifylline—Convulsion—Temozolomide—malignant glioma	0.00169	0.00771	CcSEcCtD
Pentoxifylline—Hypertension—Temozolomide—malignant glioma	0.00169	0.00768	CcSEcCtD
Pentoxifylline—Confusional state—Carmustine—malignant glioma	0.00167	0.00758	CcSEcCtD
Pentoxifylline—Myalgia—Temozolomide—malignant glioma	0.00167	0.00757	CcSEcCtD
Pentoxifylline—Anxiety—Temozolomide—malignant glioma	0.00166	0.00755	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00165	0.00752	CcSEcCtD
Pentoxifylline—Oedema—Carmustine—malignant glioma	0.00165	0.00751	CcSEcCtD
Pentoxifylline—Discomfort—Temozolomide—malignant glioma	0.00165	0.00748	CcSEcCtD
Pentoxifylline—Infection—Carmustine—malignant glioma	0.00164	0.00746	CcSEcCtD
Pentoxifylline—Dry mouth—Temozolomide—malignant glioma	0.00163	0.00741	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Carmustine—malignant glioma	0.00162	0.00736	CcSEcCtD
Pentoxifylline—Tachycardia—Carmustine—malignant glioma	0.00161	0.00733	CcSEcCtD
Pentoxifylline—Confusional state—Temozolomide—malignant glioma	0.00161	0.00732	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Temozolomide—malignant glioma	0.0016	0.00726	CcSEcCtD
Pentoxifylline—Oedema—Temozolomide—malignant glioma	0.0016	0.00726	CcSEcCtD
Pentoxifylline—Infection—Temozolomide—malignant glioma	0.00159	0.00721	CcSEcCtD
Pentoxifylline—Anorexia—Carmustine—malignant glioma	0.00157	0.00716	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Temozolomide—malignant glioma	0.00156	0.00711	CcSEcCtD
Pentoxifylline—Skin disorder—Temozolomide—malignant glioma	0.00155	0.00705	CcSEcCtD
Pentoxifylline—Hypotension—Carmustine—malignant glioma	0.00154	0.00702	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Temozolomide—malignant glioma	0.00154	0.00702	CcSEcCtD
Pentoxifylline—Anorexia—Temozolomide—malignant glioma	0.00152	0.00692	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0015	0.00685	CcSEcCtD
Pentoxifylline—Insomnia—Carmustine—malignant glioma	0.00149	0.0068	CcSEcCtD
Pentoxifylline—Dyspnoea—Carmustine—malignant glioma	0.00147	0.0067	CcSEcCtD
Pentoxifylline—Somnolence—Carmustine—malignant glioma	0.00147	0.00668	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00145	0.00662	CcSEcCtD
Pentoxifylline—Insomnia—Temozolomide—malignant glioma	0.00144	0.00657	CcSEcCtD
Pentoxifylline—Decreased appetite—Carmustine—malignant glioma	0.00144	0.00653	CcSEcCtD
Pentoxifylline—Dyspnoea—Temozolomide—malignant glioma	0.00142	0.00647	CcSEcCtD
Pentoxifylline—Somnolence—Temozolomide—malignant glioma	0.00142	0.00646	CcSEcCtD
Pentoxifylline—Constipation—Carmustine—malignant glioma	0.00141	0.00643	CcSEcCtD
Pentoxifylline—Dyspepsia—Temozolomide—malignant glioma	0.00141	0.00639	CcSEcCtD
Pentoxifylline—Decreased appetite—Temozolomide—malignant glioma	0.00139	0.00631	CcSEcCtD
Pentoxifylline—Constipation—Temozolomide—malignant glioma	0.00136	0.00621	CcSEcCtD
Pentoxifylline—Feeling abnormal—Carmustine—malignant glioma	0.00136	0.00619	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Carmustine—malignant glioma	0.00135	0.00614	CcSEcCtD
Pentoxifylline—Feeling abnormal—Temozolomide—malignant glioma	0.00132	0.00598	CcSEcCtD
Pentoxifylline—Body temperature increased—Carmustine—malignant glioma	0.00131	0.00594	CcSEcCtD
Pentoxifylline—Abdominal pain—Carmustine—malignant glioma	0.00131	0.00594	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Temozolomide—malignant glioma	0.00131	0.00594	CcSEcCtD
Pentoxifylline—Urticaria—Temozolomide—malignant glioma	0.00127	0.00577	CcSEcCtD
Pentoxifylline—Abdominal pain—Temozolomide—malignant glioma	0.00126	0.00574	CcSEcCtD
Pentoxifylline—Body temperature increased—Temozolomide—malignant glioma	0.00126	0.00574	CcSEcCtD
Pentoxifylline—Hypersensitivity—Carmustine—malignant glioma	0.00122	0.00554	CcSEcCtD
Pentoxifylline—Asthenia—Carmustine—malignant glioma	0.00119	0.00539	CcSEcCtD
Pentoxifylline—Hypersensitivity—Temozolomide—malignant glioma	0.00118	0.00535	CcSEcCtD
Pentoxifylline—Asthenia—Temozolomide—malignant glioma	0.00115	0.00521	CcSEcCtD
Pentoxifylline—Diarrhoea—Carmustine—malignant glioma	0.00113	0.00514	CcSEcCtD
Pentoxifylline—Pruritus—Temozolomide—malignant glioma	0.00113	0.00514	CcSEcCtD
Pentoxifylline—Dizziness—Carmustine—malignant glioma	0.00109	0.00497	CcSEcCtD
Pentoxifylline—Diarrhoea—Temozolomide—malignant glioma	0.00109	0.00497	CcSEcCtD
Pentoxifylline—Dizziness—Temozolomide—malignant glioma	0.00106	0.0048	CcSEcCtD
Pentoxifylline—Vomiting—Carmustine—malignant glioma	0.00105	0.00478	CcSEcCtD
Pentoxifylline—Rash—Carmustine—malignant glioma	0.00104	0.00474	CcSEcCtD
Pentoxifylline—Dermatitis—Carmustine—malignant glioma	0.00104	0.00473	CcSEcCtD
Pentoxifylline—Headache—Carmustine—malignant glioma	0.00103	0.00471	CcSEcCtD
Pentoxifylline—Vomiting—Temozolomide—malignant glioma	0.00101	0.00462	CcSEcCtD
Pentoxifylline—Rash—Temozolomide—malignant glioma	0.00101	0.00458	CcSEcCtD
Pentoxifylline—Dermatitis—Temozolomide—malignant glioma	0.00101	0.00457	CcSEcCtD
Pentoxifylline—Headache—Temozolomide—malignant glioma	0.001	0.00455	CcSEcCtD
Pentoxifylline—Nausea—Carmustine—malignant glioma	0.000981	0.00446	CcSEcCtD
Pentoxifylline—Nausea—Temozolomide—malignant glioma	0.000948	0.00431	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT2—malignant glioma	8.35e-05	0.000277	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2—malignant glioma	8.31e-05	0.000276	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NTRK1—malignant glioma	8.3e-05	0.000276	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TERT—malignant glioma	8.28e-05	0.000275	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CD80—malignant glioma	8.22e-05	0.000273	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2—malignant glioma	8.21e-05	0.000273	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APC—malignant glioma	8.21e-05	0.000273	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CG—malignant glioma	8.21e-05	0.000273	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TERT—malignant glioma	8.19e-05	0.000272	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CAV1—malignant glioma	8.18e-05	0.000272	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGF—malignant glioma	8.11e-05	0.00027	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KDR—malignant glioma	8.09e-05	0.000269	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PDGFB—malignant glioma	8.08e-05	0.000269	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTPN11—malignant glioma	8.06e-05	0.000268	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGFR1—malignant glioma	8.04e-05	0.000267	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CD—malignant glioma	8.02e-05	0.000266	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PDGFB—malignant glioma	7.99e-05	0.000265	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	7.96e-05	0.000264	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGFR1—malignant glioma	7.95e-05	0.000264	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HIF1A—malignant glioma	7.92e-05	0.000263	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HIF1A—malignant glioma	7.83e-05	0.00026	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—F2—malignant glioma	7.79e-05	0.000259	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FN1—malignant glioma	7.79e-05	0.000259	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP3—malignant glioma	7.72e-05	0.000256	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—BRAF—malignant glioma	7.72e-05	0.000256	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CB—malignant glioma	7.7e-05	0.000256	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—BAD—malignant glioma	7.7e-05	0.000256	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CAV1—malignant glioma	7.66e-05	0.000255	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN2B—malignant glioma	7.65e-05	0.000254	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOTCH1—malignant glioma	7.62e-05	0.000253	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KDR—malignant glioma	7.58e-05	0.000252	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CAV1—malignant glioma	7.57e-05	0.000252	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ASMT—malignant glioma	7.57e-05	0.000251	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT2—malignant glioma	7.51e-05	0.000249	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KDR—malignant glioma	7.49e-05	0.000249	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—malignant glioma	7.48e-05	0.000248	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CD80—malignant glioma	7.47e-05	0.000248	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APC—malignant glioma	7.45e-05	0.000248	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CG—malignant glioma	7.45e-05	0.000248	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTK2—malignant glioma	7.43e-05	0.000247	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AKT1—malignant glioma	7.41e-05	0.000246	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	7.4e-05	0.000246	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL8—malignant glioma	7.4e-05	0.000246	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGF—malignant glioma	7.37e-05	0.000245	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTPN11—malignant glioma	7.32e-05	0.000243	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HES1—malignant glioma	7.3e-05	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—F2—malignant glioma	7.29e-05	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FN1—malignant glioma	7.29e-05	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NCOR1—malignant glioma	7.26e-05	0.000241	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CD—malignant glioma	7.22e-05	0.00024	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—BAD—malignant glioma	7.21e-05	0.000239	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—F2—malignant glioma	7.21e-05	0.000239	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FN1—malignant glioma	7.21e-05	0.000239	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—RAF1—malignant glioma	7.16e-05	0.000238	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PIK3CA—malignant glioma	7.15e-05	0.000237	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOTCH1—malignant glioma	7.14e-05	0.000237	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—BAD—malignant glioma	7.12e-05	0.000237	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BCAN—malignant glioma	7.12e-05	0.000236	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2—malignant glioma	7.07e-05	0.000235	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—KRAS—malignant glioma	7.06e-05	0.000235	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOTCH1—malignant glioma	7.05e-05	0.000234	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—BRAF—malignant glioma	7.01e-05	0.000233	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CD80—malignant glioma	6.99e-05	0.000232	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CB—malignant glioma	6.99e-05	0.000232	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APC—malignant glioma	6.98e-05	0.000232	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CG—malignant glioma	6.98e-05	0.000232	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PDGFRA—malignant glioma	6.95e-05	0.000231	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGF2—malignant glioma	6.91e-05	0.00023	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CD80—malignant glioma	6.91e-05	0.00023	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGF—malignant glioma	6.9e-05	0.000229	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CG—malignant glioma	6.9e-05	0.000229	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APC—malignant glioma	6.9e-05	0.000229	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTPN11—malignant glioma	6.86e-05	0.000228	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT2—malignant glioma	6.82e-05	0.000227	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGF—malignant glioma	6.82e-05	0.000226	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—malignant glioma	6.79e-05	0.000226	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTPN11—malignant glioma	6.78e-05	0.000225	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SPP1—malignant glioma	6.75e-05	0.000224	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL8—malignant glioma	6.72e-05	0.000223	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—BRAF—malignant glioma	6.56e-05	0.000218	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CD—malignant glioma	6.55e-05	0.000218	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PIK3CA—malignant glioma	6.49e-05	0.000216	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PIK3CA—malignant glioma	6.49e-05	0.000216	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—BRAF—malignant glioma	6.48e-05	0.000215	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MDM2—malignant glioma	6.46e-05	0.000215	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RAF1—malignant glioma	6.44e-05	0.000214	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—malignant glioma	6.42e-05	0.000213	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—KRAS—malignant glioma	6.41e-05	0.000213	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TERT—malignant glioma	6.4e-05	0.000212	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT2—malignant glioma	6.39e-05	0.000212	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB2—malignant glioma	6.37e-05	0.000212	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—malignant glioma	6.36e-05	0.000211	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT2—malignant glioma	6.31e-05	0.00021	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CB—malignant glioma	6.29e-05	0.000209	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—malignant glioma	6.28e-05	0.000209	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGF2—malignant glioma	6.27e-05	0.000208	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PDGFB—malignant glioma	6.24e-05	0.000207	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGFR1—malignant glioma	6.21e-05	0.000206	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CD—malignant glioma	6.14e-05	0.000204	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HIF1A—malignant glioma	6.12e-05	0.000203	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CA—malignant glioma	6.08e-05	0.000202	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CD—malignant glioma	6.06e-05	0.000201	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL8—malignant glioma	6.04e-05	0.000201	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—KRAS—malignant glioma	6.01e-05	0.0002	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CA—malignant glioma	6e-05	0.000199	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—KRAS—malignant glioma	5.94e-05	0.000197	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CAV1—malignant glioma	5.92e-05	0.000197	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CA—malignant glioma	5.89e-05	0.000196	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGF2—malignant glioma	5.87e-05	0.000195	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MDM2—malignant glioma	5.87e-05	0.000195	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KDR—malignant glioma	5.85e-05	0.000194	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RAF1—malignant glioma	5.85e-05	0.000194	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT1—malignant glioma	5.84e-05	0.000194	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGF2—malignant glioma	5.8e-05	0.000193	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB2—malignant glioma	5.79e-05	0.000192	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—malignant glioma	5.78e-05	0.000192	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—malignant glioma	5.78e-05	0.000192	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—IDH2—malignant glioma	5.74e-05	0.000191	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CB—malignant glioma	5.71e-05	0.00019	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—F2—malignant glioma	5.63e-05	0.000187	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FN1—malignant glioma	5.63e-05	0.000187	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—BAD—malignant glioma	5.56e-05	0.000185	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CA—malignant glioma	5.52e-05	0.000183	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOTCH1—malignant glioma	5.51e-05	0.000183	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MDM2—malignant glioma	5.5e-05	0.000183	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL8—malignant glioma	5.49e-05	0.000182	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RAF1—malignant glioma	5.48e-05	0.000182	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MMP9—malignant glioma	5.47e-05	0.000182	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CA—malignant glioma	5.45e-05	0.000181	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTEN—malignant glioma	5.43e-05	0.000181	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MDM2—malignant glioma	5.43e-05	0.00018	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB2—malignant glioma	5.42e-05	0.00018	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RAF1—malignant glioma	5.41e-05	0.00018	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.41e-05	0.00018	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CD80—malignant glioma	5.4e-05	0.000179	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2B6—malignant glioma	5.39e-05	0.000179	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APC—malignant glioma	5.39e-05	0.000179	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CG—malignant glioma	5.39e-05	0.000179	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB2—malignant glioma	5.35e-05	0.000178	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CB—malignant glioma	5.35e-05	0.000178	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGF—malignant glioma	5.33e-05	0.000177	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT1—malignant glioma	5.3e-05	0.000176	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT1—malignant glioma	5.3e-05	0.000176	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTPN11—malignant glioma	5.29e-05	0.000176	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CB—malignant glioma	5.28e-05	0.000176	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—malignant glioma	5.25e-05	0.000175	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—malignant glioma	5.24e-05	0.000174	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL8—malignant glioma	5.14e-05	0.000171	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL8—malignant glioma	5.08e-05	0.000169	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—BRAF—malignant glioma	5.06e-05	0.000168	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT1—malignant glioma	4.96e-05	0.000165	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MMP9—malignant glioma	4.96e-05	0.000165	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTEN—malignant glioma	4.93e-05	0.000164	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—IDH1—malignant glioma	4.93e-05	0.000164	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT2—malignant glioma	4.93e-05	0.000164	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—malignant glioma	4.92e-05	0.000163	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—malignant glioma	4.91e-05	0.000163	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—malignant glioma	4.91e-05	0.000163	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—malignant glioma	4.91e-05	0.000163	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT1—malignant glioma	4.91e-05	0.000163	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT3—malignant glioma	4.86e-05	0.000161	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—malignant glioma	4.86e-05	0.000161	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—malignant glioma	4.85e-05	0.000161	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT1—malignant glioma	4.81e-05	0.00016	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SPHK1—malignant glioma	4.77e-05	0.000159	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CD—malignant glioma	4.74e-05	0.000157	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CA—malignant glioma	4.69e-05	0.000156	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2C18—malignant glioma	4.68e-05	0.000155	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MMP9—malignant glioma	4.65e-05	0.000154	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—KRAS—malignant glioma	4.64e-05	0.000154	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTEN—malignant glioma	4.62e-05	0.000154	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MMP9—malignant glioma	4.59e-05	0.000153	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTEN—malignant glioma	4.57e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGF2—malignant glioma	4.54e-05	0.000151	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—malignant glioma	4.52e-05	0.00015	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT1—malignant glioma	4.51e-05	0.00015	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—malignant glioma	4.46e-05	0.000148	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT1—malignant glioma	4.45e-05	0.000148	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—malignant glioma	4.42e-05	0.000147	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT3—malignant glioma	4.41e-05	0.000147	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.41e-05	0.000146	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CA—malignant glioma	4.26e-05	0.000142	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MDM2—malignant glioma	4.24e-05	0.000141	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RAF1—malignant glioma	4.23e-05	0.00014	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB2—malignant glioma	4.18e-05	0.000139	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—malignant glioma	4.17e-05	0.000139	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KRAS—malignant glioma	4.17e-05	0.000139	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT3—malignant glioma	4.13e-05	0.000137	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CB—malignant glioma	4.13e-05	0.000137	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—malignant glioma	4.12e-05	0.000137	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—malignant glioma	4.1e-05	0.000136	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT3—malignant glioma	4.08e-05	0.000136	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.02e-05	0.000133	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—malignant glioma	4.01e-05	0.000133	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL8—malignant glioma	3.97e-05	0.000132	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.88e-05	0.000129	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—malignant glioma	3.84e-05	0.000128	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CA—malignant glioma	3.83e-05	0.000127	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT1—malignant glioma	3.83e-05	0.000127	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—malignant glioma	3.8e-05	0.000126	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—malignant glioma	3.79e-05	0.000126	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—malignant glioma	3.79e-05	0.000126	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KRAS—malignant glioma	3.79e-05	0.000126	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTT1—malignant glioma	3.78e-05	0.000126	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—malignant glioma	3.76e-05	0.000125	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—malignant glioma	3.71e-05	0.000123	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—malignant glioma	3.71e-05	0.000123	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP9—malignant glioma	3.59e-05	0.000119	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTEN—malignant glioma	3.57e-05	0.000119	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KRAS—malignant glioma	3.55e-05	0.000118	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS1—malignant glioma	3.54e-05	0.000118	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.53e-05	0.000117	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KRAS—malignant glioma	3.51e-05	0.000116	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CA—malignant glioma	3.48e-05	0.000116	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT1—malignant glioma	3.48e-05	0.000116	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—malignant glioma	3.37e-05	0.000112	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BCHE—malignant glioma	3.29e-05	0.000109	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CA—malignant glioma	3.26e-05	0.000108	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC5A5—malignant glioma	3.25e-05	0.000108	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—malignant glioma	3.22e-05	0.000107	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CA—malignant glioma	3.22e-05	0.000107	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT3—malignant glioma	3.19e-05	0.000106	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—malignant glioma	3.15e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT1—malignant glioma	3.13e-05	0.000104	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—malignant glioma	3.12e-05	0.000104	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.08e-05	0.000102	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.05e-05	0.000101	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—malignant glioma	2.96e-05	9.85e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—malignant glioma	2.9e-05	9.63e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT1—malignant glioma	2.84e-05	9.45e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KRAS—malignant glioma	2.74e-05	9.1e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT1—malignant glioma	2.66e-05	8.85e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.66e-05	8.83e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT1—malignant glioma	2.63e-05	8.74e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTP1—malignant glioma	2.62e-05	8.71e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CAT—malignant glioma	2.55e-05	8.47e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CA—malignant glioma	2.52e-05	8.36e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—malignant glioma	2.43e-05	8.09e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NCOR1—malignant glioma	2.41e-05	8e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT1—malignant glioma	2.06e-05	6.83e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CAV1—malignant glioma	1.96e-05	6.52e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.88e-05	6.23e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.79e-05	5.94e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARG—malignant glioma	1.73e-05	5.73e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.57e-05	5.22e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.37e-05	4.55e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—malignant glioma	1.36e-05	4.51e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTEN—malignant glioma	1.18e-05	3.93e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CA—malignant glioma	8.35e-06	2.78e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKT1—malignant glioma	6.82e-06	2.27e-05	CbGpPWpGaD
